Indo Borax and Zenrock Chemicals Launch Open Offer for Kronox Lab Sciences
Kronox Lab Sciences Ltd · Others (Uncategorized) · 05 Nov 2026, 10:00 pm
Indo Borax and Zenrock Chemicals Launch Open Offer for Kronox Lab Sciences Indo Borax and Chemicals Limited, alongside Zenrock Chemicals Private Limited (PAC), has announced an open offer to acquire up to 95,70,000 equity shares (25.79% voting share capital) of Kronox Lab Sciences Limited at ₹157.27 per share. The tendering period opens on 6th Nov'26 and closes on 20th Nov'26, with the final payment of consideration scheduled by 7th Dec'26. The Independent Directors Committee recommended the offer price as fair and reasonable, aligning with statutory valuation parameters under SEBI (SAST) Regulations.
Original exchange filing (PDF)
More announcements from Kronox Lab Sciences Ltd
- The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November .... · 11 Nov 2026
- The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 10, 2026 for Indo Borax .... · 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd · 06 Nov 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 05, 2026 for Indo Borax & Chemicals Ltd · 06 Nov 2026
- Results -Financail Resutls for the Quarter and Half Year ended September 30, 2026 · 05 Nov 2026
- Kronox Lab Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 05 Nov 2026
- Outcome of Board Meeting held on Thursday, November 05, 2026 inter to consider and approve unaudited Standalone Financial Results for the Quarter and Half Year ended September 30, 2026 · 05 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 05 Nov 2026
